| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.15B | +10.0% |
| R&D Expense | $324.0M | +5.5% |
| SG&A Expense | $1.74B | +17.5% |
| Operating Income | $130.0M | -37.2% |
| Interest Expense | $283.0M | +93.8% |
| Pre-tax Income | -$166.0M | -327.4% |
| Income Tax | $82.0M | +41.4% |
| Net Income | -$260.0M | -4433.3% |
| EPS (Basic) | -$0.74 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $331.0M | -6.5% |
| Accounts Receivable | $839.0M | +15.9% |
| Inventory | $1.03B | +63.7% |
| Current Assets | $2.74B | +28.3% |
| Total Assets | $13.44B | +20.6% |
| Current Liabilities | $1.58B | +21.8% |
| Long-term Debt | $4.56B | +87.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.0M | -104.9% |
| Capital Expenditures | $181.0M | +3.4% |
| Investing Cash Flow | -$2.11B | -880.9% |
| Financing Cash Flow | $2.08B | +2465.4% |
| Free Cash Flow | -$198.0M | -216.5% |
| -3800.0% |
| EPS (Diluted) | -$0.74 | -3800.0% |
| Total Liabilities |
| $6.52B |
| +61.3% |
| Stockholders' Equity | $6.85B | -2.6% |